ArticlePloS one2017

Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer.

Jeffrey C Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.